Global Viral Vector Manufacturing Market - Type, Application, Disease, End-User and Regional Forecasts 2018-2025


Posted May 23, 2019 by jsbkavita

Global viral vector manufacturing market has been exceptionally termed in for a value of USD 226.21 billion in 2017.

 
It is further anticipated o growth scale of more than 24.3 percent in the next five years. The Viral vectors are specific tools which have been commonly used in by the molecular biologies who deliver genetic materials into the insides of cell. The market has been attributed to the availability of the funding of advance gene therapy, with further increase in cancer, genetic disorder, and diseases.

Still, it has been restricted on high risk of undesirable outcomes in the coming future.
High number of active clinical trials to access the safety of viral vector vaccine in the North America region has also provided a major impetus to the viral vector vaccine manufacturing market. For instance, as of 2016, a clinical study named Dose-Ranging trial of safety & immunogenicity of an oral adenoviral-vector based RSV vaccines is going-on in Optimal Research Melbourne, Florida (United States),in order to detect respiratory syncytial virus (RSV). On March 2017, as per the official website of the company named American Gene Technologies International Inc (United States), has collaborated with Geo Vax Labs Inc to conduct a Phase 1 clinical trial investing AGT’s viral vector vaccines to cure HIV infection. Viral vector-based vaccines are considered one of the most promising candidates for vaccine development, hence growing R&D expenditure for the development of new medicines in North America presents a huge opportunity for the growth of viral vector vaccine manufacturing market.

Global Viral Vector Manufacturing Market is segmented based on Type, Disease, Application, and Industry.
Based on the type of disease, the global viral vector market is segmented into Genetic disorders, infectious disease, cancers and others. Currently the market is dominated by Cancer disease with 46.75% revenue share in 2017.
On the basis of type the global viral vector manufacturing market is segmented into Adenoviral, Retroviral, Adeno-associated viral and others. Among these retroviral holds the largest revenue share of 32.37% in 2017.
Viral vectors are promising tools for gene therapy and vaccines. The viral vector vaccine segment was anticipated to dominate the revenue share in 2015 with 53.43% revenue share in 2015.
Global market revenue is dominated by North America region with 47.73% revenue share in 2017.
The primary factors supporting the market dominance in the region are the strong presence of major viral vector manufacturers, higher investment on Research & Development both from research institutes and private organizations and increasing prevalence of related diseases such as cancer, infectious diseases and others.
The region is anticipated to grow at the highest CAGR of 26.7% over the forecast period.
Get a Free sample research report https://www.jsbmarketresearch.com/sample-request/global-viral-vector-manufacturing-market-and-regional-forecasts-2018-2025
Market player included in this report are:
Wuxi Apptec, CGT Catapult, Lonza, UniQure, Merck, Cobra Biologics, Oxford BioMedica, Fujifilm Diosynth Biotechnologics
The detailed segments and sub-segment of the market are explained below:
By Type:
Adenoviral,Retroviral, Adeno-Associated
By Application:
Vaccinology,Gene Therapy
By Disease:
Genetic Disorders, Infectious Diseases, Cancers
By End-User:
Research institutes, Biopharmaceutical & Pharmaceutical Companies
By Regions:
North America, U.S., Canada, Europe, UK, Germany, Asia Pacific, China, India, Japan, Latin America, Brazil, Mexico Etc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market.
https://www.jsbmarketresearch.com/healthcare-medical/global-viral-vector-manufacturing-market-and-regional-forecasts-2018-2025
About JSB Market Research

JSB market research is one of the most significant databases of online market researches and intelligence reports and services. we specialize in providing market research reports for various industries. the online portal for marketing research deals with access to global market data and assists in providing expert.

Contact Us
JSB Market Research
Phone: +917710006748
Website: www.jsbmarketresearch.com
Email: - [email protected]
Blog: https://www.jsbmarketresearch.com/blog/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By kavita
Phone 7710006748
Business Address Navi Mumbai, belapur
Country India
Categories Health , Medical
Tags industryanalysis , marketforecast , marketinsights , marketreport , global viral vector manufacturing market , healthcare and medical industry , viral vector manufacturing , viral vector vaccine manufacturing market
Last Updated May 23, 2019